Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Vascular Pharmacology|June 3, 2009
Nucleoside transporter proteinsMíriam Molina-Arcas, F Javier Casado, Marçal Pastor-Anglada
Nucleosides, Nucleotides & Nucleic Acids|July 5, 2008
Physiological and pharmacological roles of nucleoside transporter proteinsMíriam Molina-Arcas, Laia Trigueros-Motos, F Javier Casado, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
Nucleoside transporter profiles in human pancreatic cancer cells: role of hCNT1 in 2',2'-difluorodeoxycytidine- induced cytotoxicityJosé García-Manteiga, Míriam Molina-Arcas, F Javier Casado, et al.
BMC Cancer|September 29, 2012
Aquaporin 3 (AQP3) participates in the cytotoxic response to nucleoside-derived drugsLaia Trigueros-Motos, Sandra Pérez-Torras, F Javier Casado, et al.
Blood|November 2, 2002
Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemiaMíriam Molina-Arcas, Beatriz Bellosillo, F Javier Casado, et al.
The Biochemical Journal|July 4, 2013
Hypoxia and P1 receptor activation regulate the high-affinity concentrative adenosine transporter CNT2 in differentiated neuronal PC12 cellsLorena Medina-Pulido, Míriam Molina-Arcas, Carles Justicia, et al.
Virus Research|January 15, 2005
Cell entry and export of nucleoside analoguesMarçal Pastor-Anglada, Pedro Cano-Soldado, Míriam Molina-Arcas, et al.
Antiviral Therapy|February 22, 2007
3'-Azido-2',3'-dideoxythymidine (zidovudine) uptake mechanisms in T lymphocytesSergi Purcet, Gerard Minuesa, Míriam Molina-Arcas, et al.
Biochemical Pharmacology|September 13, 2006
Human equilibrative nucleoside transporter-1 (hENT1) is required for the transcriptomic response of the nucleoside-derived drug 5'-DFUR in breast cancer MCF7 cellsMíriam Molina-Arcas, Gema Moreno-Bueno, Pedro Cano-Soldado, et al.
Pageof 2